- -

Design, Synthesis, and Biological Evaluation of Novel Fluorinated Ethanolamines

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Design, Synthesis, and Biological Evaluation of Novel Fluorinated Ethanolamines

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Fustero, Santos es_ES
dc.contributor.author Cuñat, Ana C. es_ES
dc.contributor.author Flores, Sonia es_ES
dc.contributor.author Baez, Claribel es_ES
dc.contributor.author Oliver, Judit es_ES
dc.contributor.author Cynamon, Michael es_ES
dc.contributor.author Gütschow, Michael es_ES
dc.contributor.author Mertens, Matthias D. es_ES
dc.contributor.author Delgado, Oscar es_ES
dc.contributor.author Tresadem, Gary es_ES
dc.contributor.author Trabanco, Andrés A. es_ES
dc.date.accessioned 2013-11-11T12:48:41Z
dc.date.issued 2011-12-23
dc.identifier.issn 0947-6539
dc.identifier.uri http://hdl.handle.net/10251/33420
dc.description.abstract The preparation of novel fluorinated allylamines and their use as key fragments for the stereoselective synthesis of hydroxyethyl secondary amine (HEA)-type peptidomimetics is described. Our strategy employs chiral sulfinyl imines as synthesis intermediates, by treatment of hemiaminal precursors with two equivalents of vinylmagnesium bromide. The subsequent oxidation of the allylic amines to the corresponding epoxides was achieved by treatment with methyl(trifluoromethyl)dioxirane. Finally, epoxide ring opening with a range of nitrogen nucleophiles provided a library of HEA-derived peptidomimetics with a phenyldifluoromethylene moiety. The biological evaluation of these derivatives revealed compounds with remarkable BACE1 inhibitory activity. Docking studies revealed the influence of the fluorine atoms in the binding mode of the synthesized ligands. Furthermore, the biological evaluation of our final products and synthesis intermediates led to the discovery of compounds with antimicrobial activity against Mycobacterium and Nocardia species. es_ES
dc.format.extent 13 es_ES
dc.language Inglés es_ES
dc.publisher Wiley-VCH Verlag es_ES
dc.relation.ispartof Chemistry - A European Journal es_ES
dc.rights Reserva de todos los derechos es_ES
dc.subject Antimicrobials es_ES
dc.subject BACE1 es_ES
dc.subject Ethanolamines es_ES
dc.subject Fluorine es_ES
dc.subject Peptidomimetics es_ES
dc.title Design, Synthesis, and Biological Evaluation of Novel Fluorinated Ethanolamines es_ES
dc.type Artículo es_ES
dc.embargo.lift 10000-01-01
dc.embargo.terms forever es_ES
dc.identifier.doi 10.1002/chem.201102078
dc.rights.accessRights Cerrado es_ES
dc.description.bibliographicCitation Fustero, S.; Cuñat, AC.; Flores, S.; Baez, C.; Oliver, J.; Cynamon, M.; Gütschow, M.... (2011). Design, Synthesis, and Biological Evaluation of Novel Fluorinated Ethanolamines. Chemistry - A European Journal. 17:14772-14784. doi:10.1002/chem.201102078 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion http://dx.doi.org/10.1002/chem.201102078 es_ES
dc.description.upvformatpinicio 14772 es_ES
dc.description.upvformatpfin 14784 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 17 es_ES
dc.relation.senia 241513
dc.description.references Brookmeyer, R., Johnson, E., Ziegler-Graham, K., & Arrighi, H. M. (2007). Forecasting the global burden of Alzheimer’s disease. Alzheimer’s & Dementia, 3(3), 186-191. doi:10.1016/j.jalz.2007.04.381 es_ES
dc.description.references Jakob-Roetne, R., & Jacobsen, H. (2009). Die Alzheimer-Demenz: von der Pathologie zu therapeutischen Ansätzen. Angewandte Chemie, 121(17), 3074-3105. doi:10.1002/ange.200802808 es_ES
dc.description.references Jakob-Roetne, R., & Jacobsen, H. (2009). Alzheimer’s Disease: From Pathology to Therapeutic Approaches. Angewandte Chemie International Edition, 48(17), 3030-3059. doi:10.1002/anie.200802808 es_ES
dc.description.references Jellinger, K. A. (2006). Alzheimer 100 – highlights in the history of Alzheimer research. Journal of Neural Transmission, 113(11), 1603-1623. doi:10.1007/s00702-006-0578-3 es_ES
dc.description.references Hardy, J., & Higgins, G. (1992). Alzheimer’s disease: the amyloid cascade hypothesis. Science, 256(5054), 184-185. doi:10.1126/science.1566067 es_ES
dc.description.references Selkoe, D. J. (1991). The molecular pathology of Alzheimer’s disease. Neuron, 6(4), 487-498. doi:10.1016/0896-6273(91)90052-2 es_ES
dc.description.references Hardy, J. (2002). The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics. Science, 297(5580), 353-356. doi:10.1126/science.1072994 es_ES
dc.description.references Crouch, P. J., Harding, S.-M. E., White, A. R., Camakaris, J., Bush, A. I., & Masters, C. L. (2008). Mechanisms of Aβ mediated neurodegeneration in Alzheimer’s disease. The International Journal of Biochemistry & Cell Biology, 40(2), 181-198. doi:10.1016/j.biocel.2007.07.013 es_ES
dc.description.references Dillen, K., & Annaert, W. (2006). A Two Decade Contribution of Molecular Cell Biology to the Centennial of Alzheimer’s Disease: Are We Progressing Toward Therapy? International Review of Cytology, 215-300. doi:10.1016/s0074-7696(06)54005-7 es_ES
dc.description.references Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., … John, V. (1999). Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature, 402(6761), 537-540. doi:10.1038/990114 es_ES
dc.description.references Vassar, R. (1999). Beta-Secretase Cleavage of Alzheimer’s Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE. Science, 286(5440), 735-741. doi:10.1126/science.286.5440.735 es_ES
dc.description.references Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., … Gurney, M. E. (1999). Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity. Nature, 402(6761), 533-537. doi:10.1038/990107 es_ES
dc.description.references Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A., & Tang, J. (2000). Human aspartic protease memapsin 2 cleaves the beta -secretase site of beta -amyloid precursor protein. Proceedings of the National Academy of Sciences, 97(4), 1456-1460. doi:10.1073/pnas.97.4.1456 es_ES
dc.description.references Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., … Christie, G. (1999). Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase. Molecular and Cellular Neuroscience, 14(6), 419-427. doi:10.1006/mcne.1999.0811 es_ES
dc.description.references Cole, S. L., & Vassar, R. (2007). The Alzheimer’s disease Beta-secretase enzyme, BACE1. Molecular Neurodegeneration, 2(1), 22. doi:10.1186/1750-1326-2-22 es_ES
dc.description.references Maillard, M. C., Hom, R. K., Benson, T. E., Moon, J. B., Mamo, S., Bienkowski, M., … John, V. (2007). Design, Synthesis, and Crystal Structure of Hydroxyethyl Secondary Amine-Based Peptidomimetic Inhibitors of Human β-Secretase†. Journal of Medicinal Chemistry, 50(4), 776-781. doi:10.1021/jm061242y es_ES
dc.description.references Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V. (2008). Fluorine in medicinal chemistry. Chem. Soc. Rev., 37(2), 320-330. doi:10.1039/b610213c es_ES
dc.description.references Muller, K., Faeh, C., & Diederich, F. (2007). Fluorine in Pharmaceuticals: Looking Beyond Intuition. Science, 317(5846), 1881-1886. doi:10.1126/science.1131943 es_ES
dc.description.references Hagmann, W. K. (2008). The Many Roles for Fluorine in Medicinal Chemistry. Journal of Medicinal Chemistry, 51(15), 4359-4369. doi:10.1021/jm800219f es_ES
dc.description.references Tripathi, R. P., Tewari, N., Dwivedi, N., & Tiwari, V. K. (2005). Fighting tuberculosis: An old disease with new challenges. Medicinal Research Reviews, 25(1), 93-131. doi:10.1002/med.20017 es_ES
dc.description.references Khetan, S. K., & Collins, T. J. (2007). Human Pharmaceuticals in the Aquatic Environment:  A Challenge to Green Chemistry. Chemical Reviews, 107(6), 2319-2364. doi:10.1021/cr020441w es_ES
dc.description.references Mlostoń, G., Obijalska, E., & Heimgartner, H. (2010). Synthesis of β-amino-α-trifluoromethyl alcohols and their applications in organic synthesis. Journal of Fluorine Chemistry, 131(8), 829-843. doi:10.1016/j.jfluchem.2010.05.014 es_ES
dc.description.references Smits, R., Cadicamo, C. D., Burger, K., & Koksch, B. (2008). Synthetic strategies to α-trifluoromethyl and α-difluoromethyl substituted α-amino acids. Chemical Society Reviews, 37(8), 1727. doi:10.1039/b800310f es_ES
dc.description.references Fustero, S., Sanz-Cervera, J., Aceña, J., & Sánchez-Roselló, M. (2009). Nitrogen-Containing Organofluorine Derivatives: An Overview. Synlett, 2009(04), 525-549. doi:10.1055/s-0028-1087806 es_ES
dc.description.references Sorochinsky, A. E., & Soloshonok, V. A. (2010). Asymmetric synthesis of fluorine-containing amines, amino alcohols, α- and β-amino acids mediated by chiral sulfinyl group. Journal of Fluorine Chemistry, 131(2), 127-139. doi:10.1016/j.jfluchem.2009.09.015 es_ES
dc.description.references Sani, M., Volonterio, A., & Zanda, M. (2007). The Trifluoroethylamine Function as Peptide Bond Replacement. ChemMedChem, 2(12), 1693-1700. doi:10.1002/cmdc.200700156 es_ES
dc.description.references Pesenti, C., Arnone, A., Bellosta, S., Bravo, P., Canavesi, M., Corradi, E., … Zanda, M. (2001). Total synthesis of a pepstatin analog incorporating two trifluoromethyl hydroxymethylene isosteres (Tfm-GABOB) and evaluation of Tfm-GABOB containing peptides as inhibitors of HIV-1 protease and MMP-9. Tetrahedron, 57(30), 6511-6522. doi:10.1016/s0040-4020(01)00543-9 es_ES
dc.description.references Fustero, S., Flores, S., Cuñat, A. C., Jiménez, D., del Pozo, C., Bueno, J., & Sanz-Cervera, J. F. (2007). Synthesis of fluorinated allylic amines: Reaction of 2-(trimethylsilyl)ethyl sulfones and sulfoxides with fluorinated imines. Journal of Fluorine Chemistry, 128(10), 1248-1254. doi:10.1016/j.jfluchem.2007.05.006 es_ES
dc.description.references Kuduk, S. D., Marco, C. N. D., Pitzenberger, S. M., & Tsou, N. (2006). Asymmetric addition reactions of Grignard reagents to chiral 2-trifluoromethyl tert-butyl (Ellman) sulfinimine–ethanol adducts. Tetrahedron Letters, 47(14), 2377-2381. doi:10.1016/j.tetlet.2006.01.154 es_ES
dc.description.references Liu, G., Cogan, D. A., Owens, T. D., Tang, T. P., & Ellman, J. A. (1999). Synthesis of Enantiomerically PureN-tert-Butanesulfinyl Imines (tert-Butanesulfinimines) by the Direct Condensation oftert-Butanesulfinamide with Aldehydes and Ketones. The Journal of Organic Chemistry, 64(4), 1278-1284. doi:10.1021/jo982059i es_ES
dc.description.references Truong, V. L., Ménard, M. S., & Dion, I. (2007). Asymmetric Syntheses of 1-Aryl-2,2,2-trifluoroethylamines via Diastereoselective 1,2-Addition of Arylmetals to 2-Methyl-N-(2,2,2-trifluoroethylidene)propane-2-sulfinamide. Organic Letters, 9(4), 683-685. doi:10.1021/ol063001q es_ES
dc.description.references Zhao, Q.-Y., Yuan, Z.-L., & Shi, M. (2011). Highly Diastereo- and Enantioselective Vinylogous Mannich Reactions of Fluorinated Aldimines with Siloxyfurans. Advanced Synthesis & Catalysis, 353(4), 637-643. doi:10.1002/adsc.201000843 es_ES
dc.description.references Peltier, H. M., McMahon, J. P., Patterson, A. W., & Ellman, J. A. (2006). The Total Synthesis of Tubulysin D. Journal of the American Chemical Society, 128(50), 16018-16019. doi:10.1021/ja067177z es_ES
dc.description.references Fawcett, J., Griffith, G. A., Percy, J. M., & Uneyama, E. (2004). Unexpectedly Selective Formation and Reactions of Epoxycyclooctenones under Microwave-Mediated Conditions. Organic Letters, 6(8), 1277-1280. doi:10.1021/ol0496327 es_ES
dc.description.references Philippe, C., Milcent, T., Nguyen Thi Ngoc, T., Crousse, B., & Bonnet-Delpon, D. (2009). Synthesis of New Trifluoromethylated Hydroxyethylamine-Based Scaffolds. European Journal of Organic Chemistry, 2009(30), 5215-5223. doi:10.1002/ejoc.200900578 es_ES
dc.description.references Philippe, C., Milcent, T., Crousse, B., & Bonnet-Delpon, D. (2009). Non Lewis acid catalysed epoxide ring opening with amino acid esters. Organic & Biomolecular Chemistry, 7(10), 2026. doi:10.1039/b902081k es_ES
dc.description.references syn R S S R es_ES
dc.description.references Onizawa, Y., Kusama, H., & Iwasawa, N. (2008). Efficient Control of π-Alkyne and Vinylidene Complex Pathways for the W(CO)5(L)-Catalyzed Synthesis of Two Types of Nitrogen-Containing Bicyclic Compounds. Journal of the American Chemical Society, 130(3), 802-803. doi:10.1021/ja0782605 es_ES
dc.description.references Raddatz, P., Jonczyk, A., Minck, K. O., Schmitges, C. J., & Sombroek, J. (1991). Substrate analog renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites. Journal of Medicinal Chemistry, 34(11), 3267-3280. doi:10.1021/jm00115a016 es_ES
dc.description.references Gorfe, A. A., & Caflisch, A. (2005). Functional Plasticity in the Substrate Binding Site of β-Secretase. Structure, 13(10), 1487-1498. doi:10.1016/j.str.2005.06.015 es_ES
dc.description.references McGaughey, G. B., Colussi, D., Graham, S. L., Lai, M.-T., Munshi, S. K., Nantermet, P. G., … Holloway, M. K. (2007). β-Secretase (BACE-1) inhibitors: Accounting for 10s loop flexibility using rigid active sites. Bioorganic & Medicinal Chemistry Letters, 17(4), 1117-1121. doi:10.1016/j.bmcl.2006.11.003 es_ES
dc.description.references Craig, I. R., Essex, J. W., & Spiegel, K. (2010). Ensemble Docking into Multiple Crystallographically Derived Protein Structures: An Evaluation Based on the Statistical Analysis of Enrichments. Journal of Chemical Information and Modeling, 50(4), 511-524. doi:10.1021/ci900407c es_ES
dc.description.references Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003). Improved protein-ligand docking using GOLD. Proteins: Structure, Function, and Bioinformatics, 52(4), 609-623. doi:10.1002/prot.10465 es_ES
dc.description.references Chen, P. (2006). Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro. Journal of Antimicrobial Chemotherapy, 58(2), 332-337. doi:10.1093/jac/dkl227 es_ES
dc.description.references Nikonenko, B. V., Protopopova, M., Samala, R., Einck, L., & Nacy, C. A. (2007). Drug Therapy of Experimental Tuberculosis (TB): Improved Outcome by Combining SQ109, a New Diamine Antibiotic, with Existing TB Drugs. Antimicrobial Agents and Chemotherapy, 51(4), 1563-1565. doi:10.1128/aac.01326-06 es_ES
dc.description.references R R 14 b 15 50 es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem